A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Cigna Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 27,586 shares of CI stock, worth $7.73 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
27,586
Previous 26,073 5.8%
Holding current value
$7.73 Million
Previous $8.62 Million 10.88%
% of portfolio
0.03%
Previous 0.03%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$319.12 - $367.1 $482,828 - $555,422
1,513 Added 5.8%
27,586 $9.56 Million
Q2 2024

Jul 26, 2024

SELL
$330.57 - $364.08 $682,296 - $751,461
-2,064 Reduced 7.34%
26,073 $8.62 Million
Q1 2024

Apr 24, 2024

BUY
$297.82 - $363.34 $376,742 - $459,625
1,265 Added 4.71%
28,137 $10.2 Million
Q4 2023

Feb 09, 2024

SELL
$257.49 - $318.89 $173,290 - $214,612
-673 Reduced 2.44%
26,872 $8.05 Million
Q3 2023

Oct 24, 2023

SELL
$268.69 - $299.4 $76,039 - $84,730
-283 Reduced 1.02%
27,545 $7.88 Million
Q2 2023

Jul 13, 2023

SELL
$242.64 - $280.6 $131,268 - $151,804
-541 Reduced 1.91%
27,828 $7.81 Million
Q1 2023

May 11, 2023

SELL
$254.03 - $321.4 $584,014 - $738,898
-2,299 Reduced 7.5%
28,369 $7.25 Million
Q4 2022

Feb 08, 2023

BUY
$285.73 - $339.09 $799,186 - $948,434
2,797 Added 10.04%
30,668 $10.2 Million
Q3 2022

Oct 17, 2022

BUY
$264.84 - $294.15 $821,003 - $911,864
3,100 Added 12.51%
27,871 $7.73 Million
Q2 2022

Jul 13, 2022

BUY
$242.23 - $272.4 $124,263 - $139,741
513 Added 2.11%
24,771 $6.53 Million
Q1 2022

May 12, 2022

SELL
$217.56 - $245.83 $987,069 - $1.12 Million
-4,537 Reduced 15.76%
24,258 $5.81 Million
Q4 2021

Feb 03, 2022

BUY
$191.9 - $231.65 $710,221 - $857,336
3,701 Added 14.75%
28,795 $6.61 Million
Q3 2021

Nov 02, 2021

BUY
$200.16 - $238.3 $231,985 - $276,189
1,159 Added 4.84%
25,094 $5.02 Million
Q2 2021

Aug 10, 2021

BUY
$231.97 - $266.91 $17,397 - $20,018
75 Added 0.31%
23,935 $5.67 Million
Q1 2021

May 07, 2021

SELL
$203.27 - $247.55 $96,146 - $117,091
-473 Reduced 1.94%
23,860 $5.77 Million
Q4 2020

Feb 04, 2021

SELL
$163.4 - $221.11 $221,570 - $299,825
-1,356 Reduced 5.28%
24,333 $5.07 Million
Q3 2020

Oct 29, 2020

SELL
$160.5 - $190.5 $1.11 Million - $1.31 Million
-6,886 Reduced 21.14%
25,689 $4.35 Million
Q2 2020

Jul 27, 2020

BUY
$163.84 - $215.84 $1.7 Million - $2.24 Million
10,385 Added 46.8%
32,575 $6.11 Million
Q1 2020

May 08, 2020

SELL
$130.06 - $222.56 $2.98 Million - $5.1 Million
-22,937 Reduced 50.83%
22,190 $3.93 Million
Q4 2019

Feb 04, 2020

BUY
$147.19 - $206.47 $551,226 - $773,230
3,745 Added 9.05%
45,127 $9.23 Million
Q3 2019

Nov 06, 2019

BUY
$146.27 - $179.96 $345,928 - $425,605
2,365 Added 6.06%
41,382 $6.28 Million
Q3 2019

Oct 28, 2019

BUY
$146.27 - $179.96 $5.71 Million - $7.02 Million
39,017 New
39,017 $5.92 Million
Q2 2019

Aug 15, 2019

SELL
$145.49 - $169.13 $2.26 Million - $2.63 Million
-15,526 Closed
0 $0
Q1 2019

May 08, 2019

SELL
$159.69 - $199.81 $53,336 - $66,736
-334 Reduced 2.11%
15,526 $0
Q4 2018

Feb 05, 2019

BUY
$178.01 - $224.84 $2.82 Million - $3.57 Million
15,860 New
15,860 $3.01 Million

Others Institutions Holding CI

About Cigna Corp


  • Ticker CI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 305,116,000
  • Market Cap $85.5B
  • Description
  • Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health c...
More about CI
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.